Showing results (171-180 of 6,836) with videos related to
Sort By:
Pageof 684
Archives of Toxicology|October 31, 2023
Critical assessment of the endocrine potential of Linalool and Linalyl acetate: proactive testing strategy assessing estrogenic and androgenic activity of Lavender oil main componentsLars Hareng, Susanne N Kolle, Caroline Gomes, et al.Archives of Toxicology|August 29, 2023
Adverse outcome pathway for pregnane X receptor-induced hypercholesterolemiaAnna Itkonen, Jukka Hakkola, Jaana RysäArchives of Toxicology|September 4, 2023
Confirmation that Hermann Muller was dishonest in his Nobel Prize LectureEdward J CalabreseArchives of Toxicology|August 12, 2023
Issue analysis: key characteristics approach for identifying endocrine disruptorsChristopher J BorgertArchives of Toxicology|August 24, 2023
Sex-specific transgenerational effects of preconception exposure to arsenite: metabolic phenotypes of C57BL/6 offspringBingzhen Shang, Abhishek Venkatratnam, Tianyi Liu, et al.Archives of Toxicology|August 24, 2023
Basic concepts of mixture toxicity and relevance for risk evaluation and regulationDenise Bloch, Patrick Diel, Bernd Epe, et al.Archives of Toxicology|August 23, 2023
A-agents, misleadingly known as "Novichoks": a narrative reviewJakub Opravil, Jaroslav Pejchal, Vladimir Finger, et al.Archives of Toxicology|October 15, 2023
In silico and in vitro metabolism studies of the new synthetic opiate AP-237 (bucinnazine) using bioinformatics toolsRomain Pelletier, Alexis Bourdais, Nicolas Fabresse, et al.Archives of Toxicology|October 13, 2023
Rifabutin but not rifampicin can partly out-balance P-glycoprotein induction by concurrent P-glycoprotein inhibition through high affinity binding to the inhibitory siteLottida Phondeth, Rajamanikkam Kamaraj, Julie Nilles, et al.Archives of Toxicology|October 24, 2023
Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 miceJia-Long Fang, Michelle M Vanlandingham, Greg R Olson, et al.Pageof 684